<?xml version="1.0" encoding="UTF-8"?>
<Label drug="butalbital0" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">      ADVERSE REACTIONS  

  The most frequent adverse reactions are drowsiness and dizziness. Less frequent adverse reactions are lightheadedness and gastrointestinal disturbances including nausea, vomiting, and flatulence. A single incidence of bone marrow suppression has been reported with the use of butalbital, aspirin, and caffeine capsules. Several cases of dermatological reactions including toxic epidermal necrolysis and erythema multiforme have been reported.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
